Higher dose and shorter treatment of key antibiotic proven to be safe for TB patients

A higher dose and shorter treatment time of a cornerstone tuberculosis (TB) drug has proven to be safe for patients, according to a clinical trial led by researchers at St George’s, University of London and results published in NEJM Evidence.

Nonprofit tracks surge in medication abortions as SCOTUS gears up for hearing

Medication abortions accounted for 63% of US abortions last year, due in part to expanded access via telehealth services, according to new data from the

March 20, 2024

January 2025 Psychedelic Patent Update: Lykos’ New Continuation Applications; Ambio Files on Ibogaine & Magnesium – Psychedelic Alpha

Written by Psychedelic Alpha’s Noah Smith with support from Editor-at-Large and patent attorney Graham Pechenik of Calyx Law. The Psychedelic Patent Update provides headline figures

February 25, 2025

Eli Lilly and Ro’s unlikely relationship

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.